Evidence map›Paper›PMID 34260925›Full record

ArticleCell reports2021

Protein phosphatase 1 acts as a RIF1 effector to suppress DSB resection prior to Shieldin action.

Shin-Ya Isobe, Shin-Ichiro Hiraga, Koji Nagao, Hiroyuki Sasanuma, Anne D Donaldson, Chikashi Obuse

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 21 citations in OpenAlex.

  1. Mechanisms and disease relevance of DNA break repair pathway choice.Nature reviews. Molecular cell biology · 2026
    Review
  2. Article
  3. Article
  4. Variable thresholds for phosphorylation targets of the ERK signaling pathway.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Shin-Ya IsobeDepartment of Biological Sciences, Graduate School of Science, Osaka University, 1-1 Machikaneyama-Cho, Toyonaka, Osaka 560-0043, Japan.
Shin-Ichiro HiragaInstitute of Medical Sciences, School of Medicine, Medical Sciences & Nutrition, University of Aberdeen, Aberdeen AB25 2ZD, UK.
Koji NagaoDepartment of Biological Sciences, Graduate School of Science, Osaka University, 1-1 Machikaneyama-Cho, Toyonaka, Osaka 560-0043, Japan.
Hiroyuki SasanumaDepartment of Genome Medicine, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
Anne D DonaldsonInstitute of Medical Sciences, School of Medicine, Medical Sciences & Nutrition, University of Aberdeen, Aberdeen AB25 2ZD, UK.
Chikashi ObuseDepartment of Biological Sciences, Graduate School of Science, Osaka University, 1-1 Machikaneyama-Cho, Toyonaka, Osaka 560-0043, Japan. Electronic address: obuse@bio.sci.osaka-u.ac.jp.
Osaka University · JPUniversity of Aberdeen · GBTokyo Metropolitan Institute of Medical Science · JP

Funding

Cancer Research UK 19059Cancer Research UK C1445/A19059
6 · The paper itself

Abstract

DNA double-strand breaks (DSBs) are repaired mainly by non-homologous end joining (NHEJ) or homologous recombination (HR). RIF1 negatively regulates resection through the effector Shieldin, which associates with a short 3' single-stranded DNA (ssDNA) overhang by the MRN (MRE11-RAD50-NBS1) complex, to prevent further resection and HR repair. In this study, we show that RIF1, but not Shieldin, inhibits the accumulation of CtIP at DSB sites immediately after damage, suggesting that RIF1 has another effector besides Shieldin. We find that protein phosphatase 1 (PP1), a known RIF1 effector in replication, localizes at damage sites dependent on RIF1, where it suppresses downstream CtIP accumulation and limits the resection by the MRN complex. PP1 therefore acts as a RIF1 effector distinct from Shieldin. Furthermore, PP1 deficiency in the context of Shieldin depletion elevates HR immediately after irradiation. We conclude that PP1 inhibits resection before the action of Shieldin to prevent precocious HR in the early phase of the damage response.

Indexed as

DNA Breaks, Double-StrandedBase SequenceBRCA1 ProteinCell Cycle ProteinsDNA-Binding ProteinsEndodeoxyribonucleasesHeLa CellsHomologous RecombinationHumansMultiprotein ComplexesPoly(ADP-ribose) Polymerase InhibitorsProtein BindingProtein Phosphatase 1Telomere-Binding ProteinsBRCA1 ProteinCell Cycle ProteinsDNA-Binding ProteinsEndodeoxyribonucleasesMultiprotein ComplexesPoly(ADP-ribose) Polymerase InhibitorsProtein Phosphatase 1RBBP8 protein, humanRif1 protein, humanSHLD1 protein, humanTelomere-Binding ProteinsCtIPHRMRNNHEJOlaparibPathway choicePP1ResectionRIF1Shieldin

Identifiers

PMID34260925
PMCPMC8293623
OpenAlexW3179066945

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.